Dr. Maureen Cooper obtained her veterinary degree at the Western College of Veterinary Medicine in Saskatoon, Saskatchewan, Canada, completed her residency in Veterinary Oncology and then became a Fellow in the Australian College of Veterinary Scientists in Oncology in 2010.
Cancer treatments and advice are always changing, that is one of the great things about our profession - you are always learning new things! Immunotherapy is a new and exciting field in terms of fighting cancer. There are now vaccines available for melanoma and studies have shown significant improvements in outcomes to be made when combining immunotherapy with other standard treatments. There is also a lymphoma vaccine and osteosarcoma vaccine undergoing clinical trials. Whilst these latter two are not available in Australia, if they show favourable results, hopefully we will have access to these soon. More cutting edge immunotherapy involves using CAR-T cells (chimeric antigen receptor). In brief summary this involves harvesting the patients own lymphocytes, training them to fight the specific cancer and placing them back in the body to do the ‘dirty work’. Whilst this is quite expensive and requires skilled administrators, with time should this be a successful treatment hopefully there will be less costly veterinary applications.
1. Lymphoma is by far the most common cancer we see. In dogs; diffuse, large, B cell (DLBCL) peripheral lymphoma is the most common type; however we see a broad range of lymphoid cancers in dogs.
2. Mast cell tumours
3. Anal sac adenocarcinoma
4. Osteosarcoma
5. Melanoma
1. Lymphoma is by far the most common cancer we see in cats. This is really a broad term for a large group of lymphoid cancers. In cats we most commonly see EATL type 1 and type 2 which are different types of intestinal lymphoma. Other types of lymphoid cancers we treat in cats include leukaemia’s and other lymphoma’s.
2. Squamous cell carcinoma is also frequently seen, in particular given the UV exposure in Australia.
3. Other general visceral carcinomas
4. Mammary carcinomas
We are seeing more histiocytic cancers and more indolent lymphomas. In regards to histiocytic cancers, this may be due to better diagnostics and classifications from our general practitioners and pathologists. In the past histiocytic cancer may have been misclassified as other cancers such as splenic sarcomas or synovial cell sarcomas.
Likewise, indolent lymphoma seems to be on the rise. These forms of lymphoid cancer comprise 5-30% of all canine lymphoma. I’m not sure whether these are becoming more prevalent or whether the oncology and pathology communities are becoming better at separating this subtype of cancer from the intermediate and higher grade forms.
There are really very few, if any cancers, where we can not make a difference in terms of improvement in quality of life or outcome. Even with cancers that have poor prognosis there are often palliative care options which can be implemented.
'Stop giving up on cancer so quickly!’ Often in our industry a diagnosis of cancer is inferred to be an end point, we feel this needs to change. Cancer is the only chronic disease you can cure and often pets can have a great quality of life whilst living with this disease. Many of our clients are well educated in terms of diagnostics and treatments for cancer thanks to our great general practitioners and to the media. Often clients will want to discuss new and potential cancer treatments; it is up to the veterinary industry to offer options for clients to gain more information so that they can make an educated decision regarding their pets cancer. This is where oncologists can partner with general practitioners to help these pet owners.
Communication is key. During their initial consultation we will discuss the cancer diagnosis in detail but also present various other options. Once the client has indicated how they would like to proceed we then give more detailed advice tailored to the individual pet. No patient is exactly the same and it is important that we adjust our advice and treatment for each pet. We provide detailed handouts regarding the patient’s cancer, the treatment recommended and estimates for potential tests and treatment. Finally, should they undergo treatment they are given a detailed discharge sheet.
We've put together the top 10 oncology resources from the VetCheck library to help you educate your customers on treatment options, prognoses and more.
2.What to expect with chemotherapy
3.What to expect with radiation therapy
7.Anal sac adenocarinoma in dogs